Sanofi and Boehringer Ingelheim confirm closing of business swap on January 1st 2017 (Form 8-K, Exhibit 99.1) (2017)

Government Record · Sanofi and Boehringer Ingelheim · January 2, 2017

Sanofi, 2017-01-02: The 2017 swap in which Sanofi transferred Merial to Boehringer Ingelheim in exchange for Boehringer's consumer healthcare business.

Sanofi and Boehringer Ingelheim confirmed today that the strategic transaction signed in June 2016, which consists of an exchange of Sanofi's animal health business (Merial) and Boehringer Ingelheim's consumer healthcare (CHC) business, has been successfully closed in most markets on January 1st 2017.

Sanofi, 2017-01-02: The 2017 swap in which Sanofi transferred Merial to Boehringer Ingelheim in exchange for Boehringer's consumer healthcare business. F4. US federal filing exhibit (public domain), HTML, hence LINK. Closing 2017-01-01, announced 2017-01-02; transactions signed June 2016 after exclusive negotiations from December 2015; closing in Mexico and the India swap were delayed pending approvals. Corroborated by Boehringer Ingelheim's own 2017-04-05 press release stating it 'finalised the acquisition of Merial on 1 January 2017'. The Green Book now lists Ivomec and Heartgard under Boehringer Ingelheim Animal Health USA, Inc.